The m6A modification of LINC01133 suppresses ER+ breast cancer progression by modulating IGF2BP2 protein stability via a ubiquitination-dependent mechanism
BackgroundBreast cancer is characterized as highly heterogenous and is a representative model to understand how molecular features of tumor biology determine therapeutic strategy. LINC01133 exhibits opposing expressing patterns across different breast cancer subtypes, yet its roles and mechanisms in...
Tallennettuna:
| Päätekijät: | Mai-dong Li, Ben-jie Shan, Lei Wang, Shuang Gao, Li Hao, Hai-yang Yu, Yue-yin Pan |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | englanti |
| Julkaistu: |
Frontiers Media S.A.
2025-06-01
|
| Sarja: | Frontiers in Oncology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1608574/full |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia
-
The biological roles and molecular mechanisms of m6A reader IGF2BP1 in the hallmarks of cancer
Tekijä: Li Qiu, et al.
Julkaistu: (2025-09-01) -
IGF2BP2 binding to CPSF6 facilitates m6A‐mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer
Tekijä: Xin Luo, et al.
Julkaistu: (2025-07-01) -
Hsa_circ_0020491 promotes polycystic ovary syndrome by interacting with IGF2BP2 through regulation of granular cell autophagy and mitochondrial dysfunction
Tekijä: XiaLing Huang, et al.
Julkaistu: (2025-12-01) -
IGF2BP3 Modulates mRNA Splicing and Stability to Promote Trophoblast Progression via Interaction with PDE3A and Suppression by miR-196a-5p in Preeclampsia
Tekijä: Chunyan Li, et al.
Julkaistu: (2025-05-01) -
LINC2781 enhances antiviral immunity against coxsackievirus B5 infection by activating the JAK-STAT pathway and blocking G3BP2-mediated STAT1 degradation
Tekijä: Jiayu Zhang, et al.
Julkaistu: (2025-07-01)